Figure 7. The prognostic value of peroxiredoxin (PRDX) family expression in overall survival (OS) of all ovarian cancer patients.
(A) OS curves were plotted for PRDX1 (n=1656). (B) OS curves were plotted for PRDX2 (n=1656). (C) OS curves were plotted for PRDX3 (n=1656). (D) OS curves were plotted for PRDX4 (n=1656). (E) OS curves were plotted for PRDX5 (n=655). (F) OS curves were plotted for PRDX6 (n=1656).